Purdue Pharma files notice of appeal in Endo patent case; commits to expedited process.

(From Chemical Business NewsBase - Press Release)

Purdue Pharma LP filed a Notice of Appeal in the US District Court for the Southern District of New York, stating that the company will ask the US Court of Appeals for the Federal Circuit to overturn the District Court's 5 Jan 2004 ruling that certain patents for OxyContin (oxycodone HCl controlled-release) Tablets are unenforceable against Endo Pharmaceuticals Inc (Endo). On 5 Jan 2004, Judge Sidney Stein found that, while Endo had infringed three of Purdue …